Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Xenon Pharmaceuticals beat estimated earnings by 5.19%, reporting an EPS of $-0.73 versus an estimate of $-0.77.
Revenue was down $132 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 8.29% increase in the share price the next day.
Here’s a look at Xenon Pharmaceuticals’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.70 | -0.62 | -0.58 | -0.52 |
| EPS Actual | -0.72 | -0.63 | -0.57 | -0.57 |
| Revenue Estimate | 400K | 570K | 2.28M | 3.02M |
| Revenue Actual | 0 | 0 | 0 | 132K |
To track all earnings releases for Xenon Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
